Published on Thursday March 06, 2014
Performing a bioequivalence trial of a sedative drug
Smooth Drug Development is performing a bioequivalence trial of a sedative drug.
Bioequivalence trials are performed for non-biological generics to assess absorption and excretion of the drug in healthy volunteers to test a hypothesis of pharmacological similarity of the original and generic drugs.
Due to a well-coordinated team, partnership with clinical sites and bioanalytical laboratories, we guarantee study performance with high quality of data and documents.
Smooth Drug Development partners with a leading pharmacological research site in Russia. The site has 50 beds and database of 3000 healthy volunteers.